Selected research
Market Analysis & Forecast
Global Strains Directed Breeding Platform Market Analysis and Forecast 2026-2032
Market perspective
The global Strains Directed Breeding Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Strains Directed Breeding Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Strains Directed Breeding Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Strains Directed Breeding Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Strains Directed Breeding Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Strains Directed Breeding Platform include Ginkgo Bioworks, Amyris, Twist Bioscience, Conagen, BOTA Bio, Codexis, Novozymes, SeSaM‑Biotech GmbH and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Strains Directed Breeding Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Strains Directed Breeding Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Strains Directed Breeding Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Strains Directed Breeding Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Strains Directed Breeding Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Strains Directed Breeding Platform revenue, projected growth trends, production technology, application and end-user industry.
Strains Directed Breeding Platform Segment by Company
Ginkgo Bioworks
Amyris
Twist Bioscience
Conagen
BOTA Bio
Codexis
Novozymes
SeSaM‑Biotech GmbH
Creative Biolabs
Allonnia
C16 Biosciences
SilicoLife
Strains Directed Breeding Platform Segment by Type
Traditional Breeding Platform
Gene Editing Platform
Synthetic Biology Platform
Others
Strains Directed Breeding Platform Segment by Application
Biomedicine
Agriculture
Food
Chemical Industry
Others
Strains Directed Breeding Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Strains Directed Breeding Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Strains Directed Breeding Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Strains Directed Breeding Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Strains Directed Breeding Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Strains Directed Breeding Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Strains Directed Breeding Platform revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional Breeding Platform
- Gene Editing Platform
- Synthetic Biology Platform
- Others
Applications
- Biomedicine
- Agriculture
- Food
- Chemical Industry
- Others
Companies covered
- Ginkgo Bioworks
- Amyris
- Twist Bioscience
- Conagen
- BOTA Bio
- Codexis
- Novozymes
- SeSaM‑Biotech GmbH
- Creative Biolabs
- Allonnia
- C16 Biosciences
- SilicoLife
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Strains Directed Breeding Platform Market by Type
- 1.2.1 Global Strains Directed Breeding Platform Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Traditional Breeding Platform
- 1.2.3 Gene Editing Platform
- 1.2.4 Synthetic Biology Platform
- 1.2.5 Others
- 1.3 Strains Directed Breeding Platform Market by Application
- 1.3.1 Global Strains Directed Breeding Platform Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biomedicine
- 1.3.3 Agriculture
- 1.3.4 Food
- 1.3.5 Chemical Industry
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Strains Directed Breeding Platform Market Dynamics
- 2.1 Strains Directed Breeding Platform Industry Trends
- 2.2 Strains Directed Breeding Platform Industry Drivers
- 2.3 Strains Directed Breeding Platform Industry Opportunities and Challenges
- 2.4 Strains Directed Breeding Platform Industry Restraints
3 Global Growth Perspective
- 3.1 Global Strains Directed Breeding Platform Market Perspective (2021-2032)
- 3.2 Global Strains Directed Breeding Platform Growth Trends by Region
- 3.2.1 Global Strains Directed Breeding Platform Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Strains Directed Breeding Platform Market Size by Region (2021-2026)
- 3.2.3 Global Strains Directed Breeding Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Strains Directed Breeding Platform Revenue by Players
- 4.1.1 Global Strains Directed Breeding Platform Revenue by Players (2021-2026)
- 4.1.2 Global Strains Directed Breeding Platform Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Strains Directed Breeding Platform Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Strains Directed Breeding Platform Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Strains Directed Breeding Platform Key Players Headquarters & Area Served
- 4.4 Global Strains Directed Breeding Platform Players, Product Type & Application
- 4.5 Global Strains Directed Breeding Platform Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Strains Directed Breeding Platform Market CR5 and HHI
- 4.6.3 2025 Strains Directed Breeding Platform Tier 1, Tier 2, and Tier 3
5 Strains Directed Breeding Platform Market Size by Type
- 5.1 Global Strains Directed Breeding Platform Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 5.3 Global Strains Directed Breeding Platform Revenue Market Share by Type (2021-2032)
6 Strains Directed Breeding Platform Market Size by Application
- 6.1 Global Strains Directed Breeding Platform Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 6.3 Global Strains Directed Breeding Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Ginkgo Bioworks
- 7.1.1 Ginkgo Bioworks Company Information
- 7.1.2 Ginkgo Bioworks Business Overview
- 7.1.3 Ginkgo Bioworks Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.1.4 Ginkgo Bioworks Strains Directed Breeding Platform Product Portfolio
- 7.1.5 Ginkgo Bioworks Recent Developments
- 7.2 Amyris
- 7.2.1 Amyris Company Information
- 7.2.2 Amyris Business Overview
- 7.2.3 Amyris Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.2.4 Amyris Strains Directed Breeding Platform Product Portfolio
- 7.2.5 Amyris Recent Developments
- 7.3 Twist Bioscience
- 7.3.1 Twist Bioscience Company Information
- 7.3.2 Twist Bioscience Business Overview
- 7.3.3 Twist Bioscience Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.3.4 Twist Bioscience Strains Directed Breeding Platform Product Portfolio
- 7.3.5 Twist Bioscience Recent Developments
- 7.4 Conagen
- 7.4.1 Conagen Company Information
- 7.4.2 Conagen Business Overview
- 7.4.3 Conagen Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.4.4 Conagen Strains Directed Breeding Platform Product Portfolio
- 7.4.5 Conagen Recent Developments
- 7.5 BOTA Bio
- 7.5.1 BOTA Bio Company Information
- 7.5.2 BOTA Bio Business Overview
- 7.5.3 BOTA Bio Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.5.4 BOTA Bio Strains Directed Breeding Platform Product Portfolio
- 7.5.5 BOTA Bio Recent Developments
- 7.6 Codexis
- 7.6.1 Codexis Company Information
- 7.6.2 Codexis Business Overview
- 7.6.3 Codexis Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.6.4 Codexis Strains Directed Breeding Platform Product Portfolio
- 7.6.5 Codexis Recent Developments
- 7.7 Novozymes
- 7.7.1 Novozymes Company Information
- 7.7.2 Novozymes Business Overview
- 7.7.3 Novozymes Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.7.4 Novozymes Strains Directed Breeding Platform Product Portfolio
- 7.7.5 Novozymes Recent Developments
- 7.8 SeSaM‑Biotech GmbH
- 7.8.1 SeSaM‑Biotech GmbH Company Information
- 7.8.2 SeSaM‑Biotech GmbH Business Overview
- 7.8.3 SeSaM‑Biotech GmbH Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.8.4 SeSaM‑Biotech GmbH Strains Directed Breeding Platform Product Portfolio
- 7.8.5 SeSaM‑Biotech GmbH Recent Developments
- 7.9 Creative Biolabs
- 7.9.1 Creative Biolabs Company Information
- 7.9.2 Creative Biolabs Business Overview
- 7.9.3 Creative Biolabs Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.9.4 Creative Biolabs Strains Directed Breeding Platform Product Portfolio
- 7.9.5 Creative Biolabs Recent Developments
- 7.10 Allonnia
- 7.10.1 Allonnia Company Information
- 7.10.2 Allonnia Business Overview
- 7.10.3 Allonnia Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.10.4 Allonnia Strains Directed Breeding Platform Product Portfolio
- 7.10.5 Allonnia Recent Developments
- 7.11 C16 Biosciences
- 7.11.1 C16 Biosciences Company Information
- 7.11.2 C16 Biosciences Business Overview
- 7.11.3 C16 Biosciences Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.11.4 C16 Biosciences Strains Directed Breeding Platform Product Portfolio
- 7.11.5 C16 Biosciences Recent Developments
- 7.12 SilicoLife
- 7.12.1 SilicoLife Company Information
- 7.12.2 SilicoLife Business Overview
- 7.12.3 SilicoLife Strains Directed Breeding Platform Revenue and Gross Margin (2021-2026)
- 7.12.4 SilicoLife Strains Directed Breeding Platform Product Portfolio
- 7.12.5 SilicoLife Recent Developments
8 North America
- 8.1 North America Strains Directed Breeding Platform Revenue (2021-2032)
- 8.2 North America Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 8.2.1 North America Strains Directed Breeding Platform Revenue by Type (2021-2026)
- 8.2.2 North America Strains Directed Breeding Platform Revenue by Type (2027-2032)
- 8.3 North America Strains Directed Breeding Platform Revenue Share by Type (2021-2032)
- 8.4 North America Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 8.4.1 North America Strains Directed Breeding Platform Revenue by Application (2021-2026)
- 8.4.2 North America Strains Directed Breeding Platform Revenue by Application (2027-2032)
- 8.5 North America Strains Directed Breeding Platform Revenue Share by Application (2021-2032)
- 8.6 North America Strains Directed Breeding Platform Revenue by Country
- 8.6.1 North America Strains Directed Breeding Platform Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Strains Directed Breeding Platform Revenue by Country (2021-2026)
- 8.6.3 North America Strains Directed Breeding Platform Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Strains Directed Breeding Platform Revenue (2021-2032)
- 9.2 Europe Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 9.2.1 Europe Strains Directed Breeding Platform Revenue by Type (2021-2026)
- 9.2.2 Europe Strains Directed Breeding Platform Revenue by Type (2027-2032)
- 9.3 Europe Strains Directed Breeding Platform Revenue Share by Type (2021-2032)
- 9.4 Europe Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 9.4.1 Europe Strains Directed Breeding Platform Revenue by Application (2021-2026)
- 9.4.2 Europe Strains Directed Breeding Platform Revenue by Application (2027-2032)
- 9.5 Europe Strains Directed Breeding Platform Revenue Share by Application (2021-2032)
- 9.6 Europe Strains Directed Breeding Platform Revenue by Country
- 9.6.1 Europe Strains Directed Breeding Platform Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Strains Directed Breeding Platform Revenue by Country (2021-2026)
- 9.6.3 Europe Strains Directed Breeding Platform Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Strains Directed Breeding Platform Revenue (2021-2032)
- 10.2 China Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 10.2.1 China Strains Directed Breeding Platform Revenue by Type (2021-2026)
- 10.2.2 China Strains Directed Breeding Platform Revenue by Type (2027-2032)
- 10.3 China Strains Directed Breeding Platform Revenue Share by Type (2021-2032)
- 10.4 China Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 10.4.1 China Strains Directed Breeding Platform Revenue by Application (2021-2026)
- 10.4.2 China Strains Directed Breeding Platform Revenue by Application (2027-2032)
- 10.5 China Strains Directed Breeding Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Strains Directed Breeding Platform Revenue (2021-2032)
- 11.2 Asia Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 11.2.1 Asia Strains Directed Breeding Platform Revenue by Type (2021-2026)
- 11.2.2 Asia Strains Directed Breeding Platform Revenue by Type (2027-2032)
- 11.3 Asia Strains Directed Breeding Platform Revenue Share by Type (2021-2032)
- 11.4 Asia Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 11.4.1 Asia Strains Directed Breeding Platform Revenue by Application (2021-2026)
- 11.4.2 Asia Strains Directed Breeding Platform Revenue by Application (2027-2032)
- 11.5 Asia Strains Directed Breeding Platform Revenue Share by Application (2021-2032)
- 11.6 Asia Strains Directed Breeding Platform Revenue by Country
- 11.6.1 Asia Strains Directed Breeding Platform Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Strains Directed Breeding Platform Revenue by Country (2021-2026)
- 11.6.3 Asia Strains Directed Breeding Platform Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Strains Directed Breeding Platform Revenue (2021-2032)
- 12.2 SAMEA Strains Directed Breeding Platform Revenue by Type (2021-2032)
- 12.2.1 SAMEA Strains Directed Breeding Platform Revenue by Type (2021-2026)
- 12.2.2 SAMEA Strains Directed Breeding Platform Revenue by Type (2027-2032)
- 12.3 SAMEA Strains Directed Breeding Platform Revenue Share by Type (2021-2032)
- 12.4 SAMEA Strains Directed Breeding Platform Revenue by Application (2021-2032)
- 12.4.1 SAMEA Strains Directed Breeding Platform Revenue by Application (2021-2026)
- 12.4.2 SAMEA Strains Directed Breeding Platform Revenue by Application (2027-2032)
- 12.5 SAMEA Strains Directed Breeding Platform Revenue Share by Application (2021-2032)
- 12.6 SAMEA Strains Directed Breeding Platform Revenue by Country
- 12.6.1 SAMEA Strains Directed Breeding Platform Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Strains Directed Breeding Platform Revenue by Country (2021-2026)
- 12.6.3 SAMEA Strains Directed Breeding Platform Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst